Nordea Investment Management AB Raises Stock Position in Molina Healthcare, Inc $MOH

Nordea Investment Management AB increased its stake in Molina Healthcare, Inc (NYSE:MOH) by 2.8% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,587 shares of the company’s stock after acquiring an additional 125 shares during the quarter. Nordea Investment Management AB’s holdings in Molina Healthcare were worth $1,355,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MOH. Zions Bancorporation National Association UT purchased a new stake in Molina Healthcare in the 1st quarter worth $29,000. Deseret Mutual Benefit Administrators increased its holdings in Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company’s stock worth $30,000 after acquiring an additional 34 shares in the last quarter. Elequin Capital LP increased its holdings in Molina Healthcare by 170.6% in the 1st quarter. Elequin Capital LP now owns 92 shares of the company’s stock worth $30,000 after acquiring an additional 58 shares in the last quarter. Silver Oak Securities Incorporated purchased a new stake in Molina Healthcare in the 1st quarter worth $34,000. Finally, Allworth Financial LP increased its holdings in Molina Healthcare by 52.0% in the 1st quarter. Allworth Financial LP now owns 228 shares of the company’s stock worth $72,000 after acquiring an additional 78 shares in the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Molina Healthcare Stock Down 17.6%

Shares of NYSE:MOH opened at $160.84 on Friday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.66 and a quick ratio of 1.66. The firm has a market capitalization of $8.72 billion, a PE ratio of 9.96 and a beta of 0.55. The firm’s 50-day moving average is $184.29 and its two-hundred day moving average is $240.48. Molina Healthcare, Inc has a 1 year low of $151.95 and a 1 year high of $359.97.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.97 by ($2.13). Molina Healthcare had a return on equity of 22.60% and a net margin of 1.98%.The business had revenue of $11.48 billion for the quarter, compared to analysts’ expectations of $10.99 billion. During the same quarter last year, the company earned $6.01 earnings per share. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. Analysts predict that Molina Healthcare, Inc will post 24.4 EPS for the current year.

Insider Buying and Selling

In other news, COO James Woys bought 10,000 shares of the business’s stock in a transaction that occurred on Monday, August 4th. The shares were purchased at an average cost of $155.94 per share, for a total transaction of $1,559,400.00. Following the completion of the purchase, the chief operating officer owned 74,331 shares of the company’s stock, valued at approximately $11,591,176.14. This represents a 15.54% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Ronna Romney sold 700 shares of the company’s stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total transaction of $107,618.00. Following the sale, the director owned 17,131 shares in the company, valued at $2,633,719.94. The trade was a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on MOH. UBS Group lowered their target price on shares of Molina Healthcare from $260.00 to $180.00 and set a “neutral” rating on the stock in a research note on Friday, July 25th. Robert W. Baird lowered their target price on shares of Molina Healthcare from $373.00 to $179.00 and set a “neutral” rating on the stock in a research note on Friday, July 25th. Barclays lowered their target price on shares of Molina Healthcare from $186.00 to $185.00 and set an “equal weight” rating on the stock in a research note on Thursday, September 4th. Wall Street Zen cut shares of Molina Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday, June 29th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Molina Healthcare from $272.00 to $184.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 29th. Three equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $222.15.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.